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Purpose: Although the use of opioids is increasing in South Korea, there have been no
studies on the serious complications caused by the opioids. The aim of this study was to
investigate the rare but serious complications through medicolegal analysis.
Materials and Methods: From January 1994 to December 2019, we retrospectively
reviewed the closed cases of lawsuits involving the complications of opioids using the
database of judgments of the Supreme Court of Korea. General characteristics, opioid-
induced complications, and judicial characteristics were analyzed.
Results: Of the 46 cases, 31 cases of complications were finally included in the analysis.
There were 28 (90.3%) cases of opioid administration for acute pain and 3 (9.7%) cases for
chronic pain. The most commonly prescribed opioid was pethidine (n = 13, 41.9%), and the
most common complication was respiratory depression (n = 17, 54.8%). All except two cases
were associated with permanent injuries, including 18 (58%) deaths. Twelve (38.7%) cases
were ruled in favor of the plaintiff in the claims for damages, with a median payment of
United States dollar (USD) 126,346 (IQR: USD 77,275–379,219). Of these cases, the most
frequently admitted complaint by the court was the neglect of observation (n = 10, 32.3%),
followed by the inappropriate drug choice (n = 4, 12.9%). Eleven (36.7%) cases were
plaintiffs’ claims for violating explanation obligations, of which 2 (6.7%) were recognized
in the court.
Conclusion: Our results suggest that physicians must be aware of the serious complications
related to opioids and health policies to prevent such complications and malpractice should
be adopted.
Keywords: acute pain, adverse drug events, complications, legislation and jurisprudence,
medical liability, opioids
Introduction
Opioid analgesics have played a pivotal role in the management of acute pain and
chronic cancer pain since the 1990s.1,2 More recently, it has also played an important
role in the management of chronic non-cancer pain.3,4 Opioids have strong analgesic
potency without a ceiling effect unlike other analgesics, and it can be administered
through various routes such as transdermal, submucosal, intranasal, oral, neuraxial,
or intravenous routes.4 As a result, opioids are now being widely used for pain
management, and their use has increased dramatically in South Korea.5 According
to the Adequacy of Consumption Measure (ACM) of opioids in 2010, opioid usage in
South Korea has grown exponentially, with a 77-fold increase in ACM ratio between
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2006 and 2010.6 In addition, a recent study conducted in
South Korea also showed a dramatic increase in opioid use.7
Understandably, with the increase in opioid use, there is
growing concern about the side effects of opioids in South
Korea.8,9
Opioids can cause serious side effects despite its many
advantages, so physicians need to be careful when prescrib-
ing them.10 Opioid usage can cause a wide range of side
effects, from mild symptoms such as nausea and vomiting
to fatal complications such as respiratory depression in the
acute period of administration.11 Long-term use of opioids
can result in addiction and abuse, with its prevalence
reported to be 26% in the United States.12 In addition,
chronic opioid use has recently been reported to be asso-
ciated with long-term mortality.7 As opioid prescription
increases rapidly, the serious complications caused by
opioids are expected to increase as well.
However, to our knowledge, there have been no pre-
vious studies evaluating serious complications as a result
of opioid administration in South Korea. Therefore, in this
study, we attempted to investigate the very rare but serious
complications associated with opioid administration
through the analysis of medical malpractice lawsuits.13
Through this study, we hope to increase awareness regard-
ing catastrophic complications of opioids and to prevent
medical malpractice associated with opioid administration.
Materials and Methods
We analyzed adjudicated lawsuits that are publicly acces-
sible in the database of the Supreme Court of Korea’s
judgments. This database contains both civil and criminal
proceedings sentenced from the levels of the district court
to the Supreme Court. The details of each case were
provided to the researcher without identifiable personal
information. All medical malpractice litigations that were
sentenced from January 1, 1994 to December 31, 2019
were queried using the search terms “opioid” and “narcotic
analgesics”. We included the cases in which the malprac-
tice associated with opioid administration was contained in
the plaintiff’s claims. We excluded cases unrelated to
opioid administration based on the pain physician’s judg-
ment (J Kim and H-J Lee). This study was approved by the
institutional review board (IRB) of Seoul National
University Hospital (IRB no. 2003–048-1106).
Each lawsuit text contained a detailed description of the
case, the malpractice claims of the plaintiff, and the court
decisions regarding medical malpractice. Two board-
certified pain physicians (J Kim and H-J Lee) reviewed the
judgment texts and collected the following information: year
of the event, age, sex, underlying medical diseases, causes of
opioid administration, parameters related to opioid adminis-
tration (type, route, number of doses), and the types and
severity of the complications.
The severity of complications was evaluated using the
10-point National Association of Insurance Commissioners
(NAIC) scale where 0 is “no obvious injury” and 9 is “death”
(0: No obvious injury; 1: Emotional only; 2: Temporary
insignificant; 3: Temporary minor; 4: Temporary major; 5:
Permanent minor; 6: Permanent significant; 7: Permanent
major; 8: Permanent grave; 9: Death).14
Data regarding the detailed claims of plaintiffs, the opi-
nion of the court, and the final financial compensation
awarded were also collected. The plaintiffs’ allegations
that were related to opioid administration were classified
into the following two categories; violation of the duty of
care and violation of the duty of explanation. Each case was
also investigated to determine if it was accepted by the court.
After the first review, the violation of duty of care that was
identified in our data was further classified into the following
three categories; “Neglect of observation”, “Inappropriate
drug choice”, and “Overdose”. “Neglect of observation”
was defined as inappropriate monitoring after opioid admin-
istration. “Inappropriate drug choice” was defined as when
the administration of opioids was not appropriate consider-
ing the patient’s condition. “Overdose” was defined as the
inappropriate dosage of opioids that resulted in the occur-
rence of complications. The classification and judgment of
medical malpractice was conducted independently by two
pain physicians (J Kim and H-J Lee). In the case of a conflict
between the authors, a review by an author of medical law
and ethics (SH Shin) was conducted.
Descriptive statistics were conducted using the MedCalc
Statistical Software version 18.6 (MedCalc Software bvba,
Ostend, Belgium). Categorical data are described as percen-
tages, and continuous data are described as medians (inter-
quartile range [IQR]).
Results
There was a total of 46 cases (from 69 judicial precedents)
during the study period. Of these cases, 15 cases were
excluded and a total of 31 cases were included in the final
analysis (Figure 1). Detailed information of our cases is pro-
vided in supplementary Table 1. The clinical characteristics of
the patients are presented in Table 1. There were 28 (90.3%)
cases of opioid administration for acute pain and 3 (9.7%)
cases for chronic pain. The most common cause of opioid
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administration was acute abdominal pain (n = 9, 29%), fol-
lowed by acute postoperative pain (n=8, 25.8%). There were
two fetuses (case no. 5, 23) and one 6-month old infant (case
no. 21) among those who were adversely affected by opioid
use. In the case of the fetuses, the opioid was administered to
the pregnant woman for labor pain relief.
Table 2 shows the detailed information of opioid admin-
istration and opioid-induced complications. The most com-
monly used opioid was pethidine (n = 13, 41.9%). The most
common complication following opioid administration was
respiratory depression (n = 17, 54.8%). All except two were
associated with permanent injuries, with a total of 18
deaths.
Judgment statuses are shown in Table 3. One case was
a criminal proceeding while the others were all civil pro-
ceedings. In the criminal proceeding, the defendant was
sentenced to 10 months in a suspended sentence for the
negligence of observation after opioid administration (case
no. 31). This criminal proceeding did not overlap with the
civil proceedings. Of the 30 civil proceedings, 15 were
dismissed by the court. Three of the remaining cases were
not dismissed, but the malpractice associated with opioids
claimed by the plaintiff was not recognized. The remaining
12 claims (38.7%) associated with malpractice of opioid
administration resulted in payments to the plaintiffs, with
a median payment of United States Dollar (USD) 126,346
(IQR: USD 77,275–379,219). Violation of the duty of care
related to opioid prescription was claimed by plaintiffs in
30 cases. Of these cases, 12 (38.7%) were ruled as viola-
tion of the duty of care related to opioid prescription by
the court. This violation of duty that was ruled physician
malpractice included neglect of observation after opioid
administration (n = 10), inappropriate drug choice (n = 4),
and overdose (n = 3). Violation of the physician’s duty of
informed consent was claimed by plaintiffs in 11 (36.7%)
cases. Of these cases, 2 (6.7%) were ruled as medical
malpractice by the court. Of the cases in which the court
recognized opioid-related medical malpractices, there were
four deaths, three cases of vegetative states, and three
cases of quadriplegia.
Discussion
This study analyzed 31 medical malpractice lawsuits related
to the complications of opioid administration in the Korean
court system. Our major findings were that in the majority of
cases, opioids were administered for acute pain, not chronic
pain. The most common opioid encountered in this studywas
pethidine and the most common type of complication was
Figure 1 Flowchart of the study.
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respiratory depression. Neglect of observation after opioid
administration was the most commonly ruled physician mal-
practice. Except for two, all cases were associated with
permanent injuries.
Previous medicolegal studies on the complications of
opioid administration have been reported. According to the
analysis of the closed claims database of the American
Society of Anesthesiologists (ASA) from 2005 to 2008, 48
claims were related to opioid prescriptions, which
accounted for 94% of medication management claims (n
= 51) in chronic pain management.15 In that study, the
most common outcome was death (n = 29, 57%), followed
by addiction (n = 12, 24%). In another analysis of 35
malpractice lawsuits involving opioid-related overdose in
patients with chronic pain in the United States, there were
a total of 20 deaths and the most commonly implicated
opioid was methadone (n = 10, 50%).16 Unlike the above
two studies, we did not limit the study population to
chronic pain patients, and consequently, the results of our
study were different from them. Until the 2000s, the use of
opioids for treatment, especially in chronic non-cancer
pain, was limited in South Korea.17 However, the use of
opioids in patients with chronic non-cancer pain has
Table 1 General Characteristics of the Cases





M/F 9 (29)/13 (41.9)
Not described 9 (29)




Not described 12 (38.7)
Cause of opioid administration
Acute pain 28 (90.3)
Abdominal pain 9 (29)
Postoperative pain 8 (25.8)
Diagnostic test 3 (9.7)
Headache 2 (6.4)
Traumatic pain 3 (9.7)
Labor pain 2 (6.5)
Septic arthritis 1 (3.2)
Chronic painb 3 (9.7)
History of opioid use before event 10 (32.2)
Underlying diseases
Liver diseases 5 (16.1)
Kidney diseases 3 (9.6)
Cerebrovascular diseases 2 (6.4)
Not described 5 (16.1)
Notes: Values are presented as median (interquartile range) or number (%). aThis
included two fetuses and one 6-month-old infant. bThis included low back (n = 2)
and calf pain (n = 1).
Table 2 Detailed Information of Opioid Administration and
Opioid-Induced Complications
Characteristics Total (n = 31)
Opioids type
Pethidine 13 (41.9)
Fentanyl/Morphine 3 (9.7)/2 (6.5)
Pentazocine/Morphine/Sufentanil/Nalbuphine 1 (3.2)/1 (3.2)/1
(3.2)/1 (3.2)
Combineda 9 (29)
Concomitant use of non-opioid sedative
medications
4 (12.9)
Number of opioid administration
Single dose 14 (45.1)
2 times 4 (12.9)
≥3 times 7 (22.5)
Continuous infusionb 6 (19.3)
Adverse event or outcome contended by
plaintiffs of the total cases/Cases recognized by
the court as opioid-related malpracticec
Respiratory depression 17 (54.8)/8c (25.8)
Delayed diagnosis 2 (6.5)/2 (6.5)
Decreased consciousness 3 (9.6)/0
Opioids use disorder 3 (9.6)/1 (3.2)
Fetal hypoxia 2 (6.5)/1 (3.2)
Anaphylactic shock 1 (3.2)/1 (3.2)
Hypotension 1 (3.2)/0
Gastrointestinal dysfunction 1 (3.2)/0
Cardiac arrest 1 (3.2)/0
Onset of symptoms
In medical institution 28 (90.3)
After discharge 3 (9.6)
Severity of complications
High (NAIC score 6–9) 29d (93.5)
Medium (NAIC score 3–5) 2 (6.5)
Low (NAIC score 0–2) 0 (0)
Notes: Values are presented as median (interquartile range) or number (%). aThis
included one case with tramadol and transdermal fentanyl patch, one case with
pethidine, tramadol, transdermal fentanyl patch, and patient-controlled analgesia
using fentanyl, one case with pethidine, oxycontin, tramadol, and patient-
controlled analgesia (unknown opioid), one case with pentazocine, pethidine, mor-
phine and one case with tramadol, pethidine. bThis included patient-controlled
analgesia (2 cases), transdermal fentanyl patch (2 cases), remifentanil infusion via
infusion pump (1case) and sufentanil infusion via infusion pump (1 case). cThis
included one criminal proceeding. dThis included a total of eighteen deaths.
Abbreviation: NAIC, National Association of Insurance Commissioners.
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increased recently in Korea5,7 and the guidelines for their
use in these patients were recently published.4 Therefore,
in our study, most cases were associated with acute pain
rather than chronic pain. In addition, few cases were
associated with addiction and the most commonly used
opioid in our study was pethidine, and it was mainly used
for the treatment of acute pain.
Although we searched for cases from 1994, there were
only two cases in the 1990s and two-thirds of the cases
occurred post 2010. Since we included only the closed
cases, some lawsuits from recent years may not be included
in our study. Therefore, there may be more cases in reality
than those reported here since 2010. An analysis of the trends
in pain medicine claims of the ASA closed claims database
reported that only 2% of pain medicine claims in the 1980s
were related to medication mismanagement; however, this
has increased significantly since 2000 by 17%.18 The authors
described that this finding was associated with the national
trends of opioid prescriptions. As described in the introduc-
tion, opioid use in Korea has also increased steadily, and the
problems related to opioid overuse are expected to increase
gradually in the future. Therefore, it is meaningful to inves-
tigate the serious complications of opioid administration in
Korea and to raise its awareness among pain physicians who
commonly prescribe them.
In our study, respiratory depression was the most com-
mon complication after opioid administration. Opioids have
a direct inhibitory effect on neurons expressing μ - opioid
peptide receptors at the respiratory centers in the brainstem.
Opioid-induced respiratory depression (OIRD) leads to
decreased oxygen supply to the brain, resulting in hypoxic
brain injury. An analysis of ASA closed claim database from
1990 to 2009 found that of the 357 claims associated with
postoperative pain management, 92 claims were associated
with OIRD, of which 77% resulted in severe brain damage or
death.19 In this study, respiratory depression was the most
common complication, with very poor outcomes.
To prevent catastrophic outcomes after opioid admin-
istration, physicians need to be mindful of the possible
complications of opioids. In our study, negligence of
observation after opioid administration was the most com-
mon opioid-related malpractice recognized by the court. In
addition, despite most of these complications occurring in
inpatients, there was only one instance of administration of
naloxone, the only antidote for OIRD. Based on these
findings, we cautiously claim that there may be a lack of
vigilance and a proper monitoring system of OIRD in
Korea. According to the American society for pain man-
agement nursing (ASPMN) guidelines on monitoring for
opioid-induced sedation and respiratory depression, serial
sedation and respiratory assessments are recommended
during opioid therapy.20 The assessment of sedation is
very important in patients receiving opioid administration
because sedation precedes OIRD. It is also important to
assess the patients’ respiratory rate periodically, because
a decreased respiratory rate is a premonitory sign of
OIRD. If a patient is at risk for OIRD, it is recommended
that continuous pulse oximetry and capnography monitor-
ing be performed.21 A recent multicenter study reported
that the implementation of ASPMN guidelines related to
OIRD had a positive effect on the management of OIRD.22
It is recommended that in the outpatient setting, opioid
administration should be started with the minimum dose
and gradually increased as necessary.4 In one of the cases
not dismissed by the court, a transdermal fentanyl patch
was prescribed to an opioid-naive patient with an initial
dose of 50 mcg in an outpatient setting (case no. 18).
Although the analgesic effect may be insufficient in the
early stage, this should be explained to the patient and the
Table 3 Judicial Characteristics from 31 Cases Related to Opioid
Administration
Characteristics n = 31
Criminal proceeding 1 (3.2)
Neglect of observation 1 (3.2)
Civil proceeding 30 (96.8)
Dismissal of opioid-related malpractice 18 (58.1)
Violation of the duty of care related to opioid
prescription
Claims of plaintiffs 30 (96.8)
Recognition of the court 12 (38.7)
Neglect of observation 10 (32.3)
Inappropriate drug choice 4 (12.9)
Overdose 3 (9.7)
Violation of the duty of explanation related to
opioid prescription
Claims of plaintiffs 11 (36.7)
Recognition of the court 2 (6.7)
Amount for damage – median USDa
Claims of plaintiffsb 169,053
(98,418–627,662)
Recognition of the courtc 126,346
(77,275–379,219)
Notes: Values are presented as median (interquartile range) or number (%). aThe
exchange rate was converted to 1 United States Dollar =1165 Korean Won
considering the mean exchange rate for 2019. bThe amount was not described in
one opioid case. cThis included only events that opioid-related malpractice had not
been dismissed.
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opioid titration performed over a safe period of time. Since
OIRD is not an unavoidable complication like anaphy-
laxis, rather a preventable one, medical staff should be
watchful for this complication and a system to aid its
early detection and prevention must be in place.
In addition to practices to prevent OIRD, the following
precautions are necessary while administering opioids.
Firstly, the patient’s complete medical history which includes
pre-existing diseases should be obtained before opioid
administration. In one case in our study, pethidine use in
a patient with increased intracranial pressure from intracra-
nial bleeding was recognized as a malpractice (case no. 16).
Pethidine, which was most commonly implicated in this
study, requires caution in its use because it has many contra-
indications such as bronchial asthma, heart failure, convul-
sive disorders, and increased intracranial pressure, different
from other opioids.23 Pethidine is not recommended in both
acute and chronic pain because it has a wider side-effect
profile than other opioids but no specific advantage.24 In
one case related to anaphylaxis, it was recognized as
a malpractice to re-administer pentazocine to a patient who
had previously experienced a hypersensitivity reaction to it
(case no. 1). In patients with a history of hypersensitivity to
a specific drug, additional exposure to that may result in
anaphylaxis.25 Therefore, history taking of drug hypersensi-
tivity is very important. In addition, patients with liver or
kidney disease can overdose inadvertently if their doses are
not adjusted for impaired renal or hepatic drug clearance,
with side effects occurring at doses considered safe for the
general population.26 Secondly, opioid administration can
cause the physician to miss important diagnostic clues. In
two cases of the study, the delayed diagnoses (postoperative
compartment syndrome and small bowel perforation) due to
opioid administration were recognized as the malpractice by
the court (case no. 10, 13). In the past, the use of opioids had
been discouraged in emergencies such as acute abdominal
pain due to the concerns about masking important diagnostic
clues. However, it has been reported that opioid analgesia is
safe and does not delay diagnosis in emergencies.27
Nevertheless, accurate diagnosis should be given signifi-
cance over analgesic administration during emergencies
and physicians should not neglect the diagnosis of pain-
causing diseases while providing adequate analgesia.
Lastly, opioid abuse should be considered especially when
opioids are prescribed for long-term use.4,28 There is only
one such case in our study (case no. 3), and to date, Korea has
seemed relatively safe from this problem.9 However, the
opioid use in chronic non-cancer pain patients has recently
increased in South Korea7 and the recent legalization of
medical marijuana in South Korea could provoke the pro-
blem related to opioid abuse.29 A recently reported single-
center study in South Korea reported that one-fourth of the
study participants showed opioid use disorders.30 In the
future, this problem is expected to increase in South Korea
as seen in the Western countries. Therefore, Korean physi-
cian will have to pay attention to this problem.
The results of our study should be interpreted cautiously for
several reasons. Firstly, our study could not represent the
comprehensive features of opioid-related complications. Due
to the highly contentious nature of our data, the complications
in our study skewed toward rare and serious complications.
Further, cases that ended in agreement or arbitration have not
been included here. In a previous study of medical disputes
regarding pain management in Korea using insurance data-
base, there were no cases related to opioids.31 Another recent
study using the Korea Medical Dispute Medication and
Arbitration Agency (KMDMAA) data from 2012 to 2016
reported that a total of four cases were associated with medical
complications or drug side effects.32 According to the addi-
tional data that we directly obtained through the KMDMAA,
there were a total of six cases associated with opioids from
2012 to 2018. However, we excluded this data from the ana-
lysis because of the unavailability of detailed clinical informa-
tion to determine the causality between opioid use and
outcomes. In addition, in Korea, the act ofmedical malpractice
damage’s relief and medication for medical dispute resolution
has been enacted since 2012.33 Considering the previous legal
environment, many medical malpractices before 2012 might
not lead to litigation. Secondly, the clinical features described
in judicial sentences had limitations, especially in cases that
were dismissed. Lastly, although medical appraisers’ opinions
play an important role in judges’ malpractice decisions,
a judge’s subjectivity may also affect the decision. Despite
these limitations, this study provides useful information on
rare adverse events that would be difficult to study prospec-
tively without an expensive and time-consuming large multi-
center design. Awareness of these rare, but critical, adverse
events may help pain physicians to recognize these complica-
tions earlier, and prompt them to take remedial action before it
is too late.
Conclusion
In conclusion, healthcare professionals should be acquainted
with the risk of serious adverse events surrounding the
prescription of opioids. In addition, national health policies
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to prevent such fatal complications are necessary to ensure
patient safety and to mitigate medical liability.
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